Trial intelligence / Profile preview

Magnesium sulfate as an adjuvant to brachial plexus block for rebound pain after block resolution

ChiCTR2000029640Phase 4Recruiting

Sponsor
Southern Medical University
Start
Feb 2020
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of magnesium sulfate and ropivacaine (2 arms), sponsored by Southern Medical University. Primary endpoint: Duration of block. Started Feb 2020; status: recruiting.

02

Drugs

magnesium sulfateropivacaine

Beyond the preview

Go deeper on ChiCTR2000029640.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000029640.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call